In vitro and in vivo analysis of the human cyp3a5 promoter

被引：0
|
作者：
Nem, D. [1 ]
Qiu, H. [1 ]
Nestler, S. [1 ]
Goedtel-Armbrust, U. [1 ]
Wojnowski, L. [1 ]
机构：
[1] Univ Med Mainz, Mainz, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2010年 / 381卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [31] The genotype-phenotype association of CYP3A4 and CYP3A5 polymorphisms to midazolam clearance in vivo
    He, P
    Court, MH
    Greenblatt, DJ
    von Moltke, LL
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (10): : 1209 - 1209
  • [32] SEQUENCE OF THE 5'-FLANKING REGION OF CYP3A5 - COMPARATIVE-ANALYSIS WITH CYP3A4 AND CYP3A7
    JOUNAIDI, Y
    GUZELIAN, PS
    MAUREL, P
    VILAREM, MJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 205 (03) : 1741 - 1747
  • [33] The genotype-phenotype association of CYP3A4 and CYP3A5 polymorphisms to midazolam hydroxylation in vivo
    He, P
    Court, MH
    Greenblatt, DJ
    von Moltke, LL
    DRUG METABOLISM REVIEWS, 2004, 36 : 118 - 118
  • [34] Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism
    Westlind-Johnsson, A
    Malmebo, S
    Johansson, A
    Otter, C
    Andersson, TB
    Johansson, I
    Edwards, RJ
    Boobis, AR
    Ingelman-Sundberg, M
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (06) : 755 - 761
  • [35] Effect of five HIV protease inhibitors on CYP3A4, CYP3A5, and CYP3A7 activities in vitro
    Granfors, MT
    Kajosaari, LI
    Wang, JS
    Laitila, J
    Neuvonen, PJ
    Backman, JT
    DRUG METABOLISM REVIEWS, 2003, 35 : 48 - 48
  • [36] The genetic determinants of the CYP3A5 polymorphism
    Hustert, E
    Haberl, M
    Burk, O
    Wolbold, R
    He, YQ
    Klein, K
    Nuessler, AC
    Neuhaus, P
    Klattig, J
    Eiselt, R
    Koch, I
    Zibat, A
    Brockmöller, J
    Halpert, JR
    Zanger, UM
    Wojnowski, L
    PHARMACOGENETICS, 2001, 11 (09): : 773 - 779
  • [37] CYP3A5 contributes to PDAC chemoresistance
    Hugh Thomas
    Nature Reviews Gastroenterology & Hepatology, 2016, 13 (4) : 188 - 188
  • [38] CYP3A5 polymorphism, amlodipine and hypertension
    Zhang, Y-P
    Zuo, X-C
    Huang, Z-J
    Cai, J-J
    Wen, J.
    Duan, D. D.
    Yuan, H.
    JOURNAL OF HUMAN HYPERTENSION, 2014, 28 (03) : 145 - 149
  • [39] The algal hepatoxoxin okadaic acid is a substrate for human cytochromes CYP3A4 and CYP3A5
    Guo, Fujiang
    An, Tianying
    Rein, Kathleen S.
    TOXICON, 2010, 55 (2-3) : 325 - 332
  • [40] CYP3A5 polymorphism, amlodipine and hypertension
    Y-P Zhang
    X-C Zuo
    Z-J Huang
    J-J Cai
    J Wen
    D D Duan
    H Yuan
    Journal of Human Hypertension, 2014, 28 : 145 - 149
12345